Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2559 | Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D012141 | Respiratory Tract Infections NIH | 0.16 |
| D003141 | Communicable Diseases NIH | 0.07 |
| D007239 | Infection NIH | 0.05 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0011947 | Respiratory tract infection HPO | 0.16 |
Navigate: Correlations HPO
There is one clinical trial.
This study is a randomized controlled trial of an online, evidenced-based intervention (the ENHANCE program) that was modified to address the health and well-being challenges of COVID-19. Eligible participants will be randomized into the ENHANCE or Wait-List Control group over a 12-week period. ENHANCE participants will be introduced, and asked to practice, 10 evidenced-based principles and skills of happiness and well-being. Participants will complete an online survey about their health and well-being at baseline, midway (or 6 weeks), post-assessment (or at the end of the 12-week study), and 3-months following the end of the study.
Description: Change from baseline mood
Measure: Beck Depression Inventory - II (BDI-II) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline satisfaction with life
Measure: Satisfaction With Life Scale (SWLS) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline anxiety
Measure: Generalized Anxiety Disorder - 7 (GAD-7) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline mood
Measure: Patient Health Questionnaire (PHQ-9) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline stress
Measure: Perceived Stress Scale (PSS) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline affect
Measure: Positive and Negative Affect Scale (PANAS) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline anxiety
Measure: Health Anxiety Inventory Short-Form (HAI-SF) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline quality of life
Measure: World Health Organization Quality of Life (WHOQOL - BREF) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline meaning in life
Measure: Meaning In Life Questionnaire (MLQ) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline sleep quality
Measure: Sleep Disorder Questionnaire (SDQ) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline attachment
Measure: Measure of Attachment Qualities (MAQ) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline loneliness
Measure: University of California, Los Angeles Loneliness Scale (UCLA Loneliness Scale) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline sleep quality
Measure: Insomnia Severity Index (ISI) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline physical activity
Measure: Paffenbarger Physical Activity Questionnaire (PPAQ) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline trauma-related distress
Measure: PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (PCL-5) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Description: Change from baseline quality of life
Measure: European Quality of Life Group - 5 Dimensions - 5 Levels (EQ-5D-5L) Time: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports